Coffee Consumption and ER Status
. | 0-1 cup/d . | ≥2 cups/d . | . | . | ||||
---|---|---|---|---|---|---|---|---|
A. Patients with known coffee consumption and ER status (n = 450) | ||||||||
ER− | 6 | 56 | 62 | |||||
ER+ | 71 | 317 | 388 | |||||
77 | 373 | 450 | χ2 P = 0.09 | |||||
B. Patients carrying the CYP1A2*1F A/A genotype (n = 230) | ||||||||
ER− | 0 | 29 | 29 | |||||
ER+ | 33 | 168 | 201 | |||||
33 | 197 | 230 | χ2 P = 0.018 | |||||
C. Patients carrying at least one CYP1A2*1F C allele (n = 220) | ||||||||
ER− | 6 | 27 | 33 | |||||
ER+ | 38 | 149 | 187 | |||||
44 | 176 | 220 | χ2 P = 0.78 |
. | 0-1 cup/d . | ≥2 cups/d . | . | . | ||||
---|---|---|---|---|---|---|---|---|
A. Patients with known coffee consumption and ER status (n = 450) | ||||||||
ER− | 6 | 56 | 62 | |||||
ER+ | 71 | 317 | 388 | |||||
77 | 373 | 450 | χ2 P = 0.09 | |||||
B. Patients carrying the CYP1A2*1F A/A genotype (n = 230) | ||||||||
ER− | 0 | 29 | 29 | |||||
ER+ | 33 | 168 | 201 | |||||
33 | 197 | 230 | χ2 P = 0.018 | |||||
C. Patients carrying at least one CYP1A2*1F C allele (n = 220) | ||||||||
ER− | 6 | 27 | 33 | |||||
ER+ | 38 | 149 | 187 | |||||
44 | 176 | 220 | χ2 P = 0.78 |